Navigation Links
Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines
Date:5/24/2013

President and CEO, commented, "Sinovac Beijing's vaccine products, its bulk production plants, and its Changping filling and packaging facility have passed the GMP inspection and received the GMP certificate under the new version of GMP guidelines ahead of the year end 2013 deadline. The GMP guidelines adopted in China in March 2011 are consistent with international standards."

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu) and mumps, as well as animal rabies vaccine for canines. The Company recently concluded the phase III clinical trial for enterovirus 71 (against hand, foot and mouth disease). In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, Panflu.1, and has manufactured it for the Chinese Central Government, pursuant to the government-stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program. Sinovac is developing a number of new pipeline vaccines including vaccines for pneumococcal polysaccharides, pneumococcal conjugate, varicella and rubella. Sinovac sells its vaccines mainly in China and exports selected vaccines to Mongolia, Nepal, and the Philippines. Sinovac has also been granted a license to commercialize seasonal flu vaccine in Mexico.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995.
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
2. Sinovac Reports Unaudited First Quarter 2012 Financial Results
3. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
4. Sinovac Schedules 2012 Annual Meeting of Shareholders
5. Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
6. Sinovac Reports Unaudited Second Quarter 2012 Financial Results
7. Sinovac Holds 2012 Annual General Meeting of Shareholders
8. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
9. Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results
10. Sinovac Reports Unaudited Third Quarter 2012 Financial Results
11. Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)...  BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading ... storage and cryopreservation freeze media and ... or the "Company"), announced that the Company is scheduled to ... The Company is scheduled to present at the Conference at ... Grand Hyatt Hotel in New York City ...
(Date:5/22/2015)... The leading companies in the cardiac ... rhythm management device market dominate their competition, according ... Jude Medical, Boston Scientific and Asahi Kasei (with ... The healthcare market research publisher,s report, Cardiac ... a base year, providing forecasts for each year ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... May 5, 2011 American Regent is conducting a ... following product: Caffeine & Sodium Benzoate Injection, USP, ... # 0517-2502-10, Lot # 0084,  Exp Date  February, 2012 ... 2011 to the User or Consumer Level, is for Lot # ...
... 2011 CareFusion Corp. (NYSE: CFN ), ... for the three and nine months ended March 31, ... "Our business performed well in the quarter, ... margins through a favorable product mix and disciplined expense ...
Cached Medicine Technology:American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates 2American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates 3CareFusion Reports Third Quarter Rise in Revenue, Earnings 2CareFusion Reports Third Quarter Rise in Revenue, Earnings 3CareFusion Reports Third Quarter Rise in Revenue, Earnings 4CareFusion Reports Third Quarter Rise in Revenue, Earnings 5CareFusion Reports Third Quarter Rise in Revenue, Earnings 6CareFusion Reports Third Quarter Rise in Revenue, Earnings 7CareFusion Reports Third Quarter Rise in Revenue, Earnings 8CareFusion Reports Third Quarter Rise in Revenue, Earnings 9CareFusion Reports Third Quarter Rise in Revenue, Earnings 10CareFusion Reports Third Quarter Rise in Revenue, Earnings 11CareFusion Reports Third Quarter Rise in Revenue, Earnings 12CareFusion Reports Third Quarter Rise in Revenue, Earnings 13CareFusion Reports Third Quarter Rise in Revenue, Earnings 14
(Date:5/25/2015)... Burke Rehabilitation Hospital will welcome Samuel ... York City, to speak at Burke on Wednesday, June 3. ... Lobby Lecture series, will take place at 4:30 p.m. on ... grandson of Stanford White of McKim, Mead and White, the ... 100 years ago. , “We are thrilled to welcome Samuel ...
(Date:5/24/2015)... Pacific Prime has announced that they have launched the second ... of individual international health insurance. Titled: The Cost of Health Insurance ... health insurance in six top expat destinations, which are also popular ... Kong , Singapore , China , ... UK , Article 2 presents an in-depth look at ...
(Date:5/24/2015)... 24, 2015 Women's Excellence in ... loss. Although it is unclear about the etiology of ... factors such as metabolism, nutritional deficiencies, thyroid abnormalities and ... a comprehensive approach to evaluating the metabolic, nutritional and ... can help patients find a cause for their problem. ...
(Date:5/24/2015)... Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... will allow them to take pressure measurements in patients’ ... function. The doctor usually orders it if they have ... bladder (OAB). , Women’s Excellence in Bladder ... problems with unwanted urinary leakage or problems with overall ...
(Date:5/24/2015)... 24, 2015 EnviroLeather™ by LDI, ... Plus” – a classic, rugged leather grain with ... difficult stains, including ink, to be easily removed. ... suitable for corporate, healthcare, hospitality and education environments. ... EnviroLeather’s goal of developing products that are more ...
Breaking Medicine News(10 mins):Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2
... of access to medical care a big factor in ... half of the Americans who meet the criteria for ... survey indicates. , "There is a definite gap between ... an internist in the Yale University Robert Wood Johnson ...
... specializing in Medicare supplement insurance plans, says MARS Act could ... access to necessary services. , ... ... news, according to MedicareSupplementPlans.com: Legislation designed to remove Medicare’s annual ...
... Clients Prepare and RespondPHILADELPHIA, April 24 International SOS ... information regarding the swine flu outbreak to members of ... http://urgent.interna t ionalsos.com , ... to frequently asked questions that those in California, Texas ...
... Telemedicine Inc. announces the completion of its transformation from a telemedicine ... (TEMS™) , ... North Chelmsford, MA (PRWEB) April 24, ... transformation to a Telemedicine Encounter Management Systems company. AMD will ...
... allows for remote physician participation in real time ... -- Scottsdale, Ariz.-based GlobalMedia, an innovator ... in the practice of telemedicine, announced today that ... product line, the TransportAV, at the American Telemedicine ...
... United American Healthcare Corporation (Nasdaq: UAHC ... a managed care organization in Tennessee, today announced it ... quarter ended March 31, 2009 on Thursday, May 7, ... a conference call at 4:30 p.m. Eastern time the ...
Cached Medicine News:Health News:Many Who Should Use Statins Don't 2Health News:Many Who Should Use Statins Don't 3Health News:MedicareSupplementPlans.com Says News Legislation Could Affect Physical, Speech Therapy Benefits for Medicare Recipients 2Health News:International SOS Releases Web Site to Educate Public About Swine Flu Outbreak 2Health News:AMD Global Telemedicine Inc. to Unveil New Solutions at ATA 2009 Conference in Las Vegas 2Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 2Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 3Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 4Health News:United American Healthcare Corporation to Host Fiscal 2009 Third Quarter Results Conference Call May 7th 2
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
2.5V Incandescent source, 3X magnification, pocket-sized....
Pocket-sized instrument with 2.5X magnification....
... offer patented Sensomatic® handles that ... up and switch off when ... of light from 2.5V halogen ... of examination area. Used ...
Medicine Products: